Prof.Antonio Ceriello
The Lessons We’ve Learned from COVID 19 pandemic What to do next
Prof.Mohamed Khattab
Empagliflozin and CV Renal Benefits Across The Diabetes Continuum
Prof.Ibrahim Elebrashy
Diabetic Neuropathy
Prof.Hossam Arafa Ghazi
Role of horse technology in 2 types
Prof.Hesham El Gayar
Dapagliflozin Portfolio , a game Changer
Prof.Naglaa El Sayed
CGM impact on diabetic complications
Prof.Nabil El Kafrawy
Modulating cardio renal outcomes in patients with diabetes
Prof.Mohamed Abdel Raouf
Triglycerides An Emerging Target in Management of Diabetic Dyslipidemia
Prof.Khalifa Abdallah
Combination Therapies in T2D What Synjardy Can Add
Prof.Khaled El Hadidi
Updates in Diabetic retinopathy from ADA 2020
Prof.Ibrahim Elebrashy
Value of Quadrivalent Influenza Vaccine for Diabetic patients
Prof.Hesham Magd
Remission in type 1 DM
Prof.Nebojsa M Lalic
Continuous Glucose Measurement Present and Future
Prof.Nermine Sheriba
Rosuvastatin Ezetimibe single pill combination the first High Intensity lipid lower
Prof.Samir George
Linagliptin A simplified Approach in the management of T2D
Prof.Salah Shelbaya
B Right From The Start
Prof.Thamer Alessa
Recent Updates in T2DM Management – The CompoSIT Program
Prof.Khalifa Abdallah
The new generation of insulin
Prof.Ismail Ramadan
Central insulin resistance and it’s relation to neurological disorders
Prof.Ibrahim Elebrashy
GLP 1RA Gate to the future
Prof.Ibrahim Elebrashy
Gliclazide MR new evidence for the benefits of the patients
Prof.Hesham El Gayar
From dual to triple therapy; what is new
Prof.Hany Ragy
When and how to screen for cardiovascular complications in diabetics
Prof. Ayman Abou El Magd
Management of IHD in diabetics
Prof.Tarek El Baz
Diabetic Kidney Disease Challenges, and new insights
Prof.Silvio E Inzucchi
Comprehensive T2D management from gluco centric to holitic approach
Prof.Nabil El Naggar
Life and death of B cells innovative implications for therapeutic approaches
Prof.Mohamed Sobhy
SGLT2i From Prevention to Treatment Cardio perspective
Meet The Experts Session
Prof.Mary Nabil
Diabetes and Brain EASD 2020
Opening Cermoney
Prof.Nermine Sheriba
What Are Pcsk9 is and When To Use Them
Prof.Nermine Sheriba
Debate Which is the winner GLP 1 RA or SGLT2
Prof.Nebojsa M Lalic
Cvot Results Messages and Dilemmas
Prof.Nabil El Kafrawy
Debate Which is the winner GLP 1 RA or SGLT2
Prof.Salah Shelbaya
Management of newly diagnosed T2DM patients
Prof.Nabil El Kafrawy
A different approach in hypertension management
Prof.Nabil El Kafrawy
10 Years with DPP 4 Inhibition – Role of Sitagliptin in different T2DM population
Prof.Mohamed Khattab
SUs what's new
Prof.Mohamed Abolgheit
Liraglutide 3 0 mg filling the gap in obesity management
Prof.Martin Haluzik
Introducing Soliqua Iglarlixi
Prof.Thamer Alessa
Recent Updates in T2DM Management – The CompoSIT Program
Prof.Nabil El Kafrawy
Modulating cardio renal outcomes in patients with diabetes
Prof.Hesham El Hefnawy
SGLT 2 I Moving from safety to benefits
Prof.Mohamed Reda Halawa
Who benefits most from an early combination treatment approach for type II Diabe
Prof.Shaimaa Zewain
Type 2 Diabetes, How much of an Autoimmune origin
Prof.Haytham Badr
Management of DM in chronic liver disease
Prof.Iman Tohamy
Diabetes in the elderly
Prof.Maha Youssef
Diabetes and the kidney
Prof.Moustafa Bakrey
Hamed Osteoporosis in Diabetes Mellitus
Prof.Shaimaa Fathi
Diabetes and the liver
Prof.Islam Anan
Economic Burden of Diabetes in Egypt 1